| ATRICURE INC. DL-,001 |
| USA |
| Gesundheit |
| US04963C2098 / A0ES9W |
| A5I (Frankfurt) / ATRC (NASDAQ) |
| FRA:A5I, ETR:A5I, A5I:GR, NASDAQ:ATRC |
| - |
| https://www.atricure.com/ |
|
AtriCure, Inc. is a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company develops and provides advanced medical technologies used by electroph..
>Volltext.. |
| 1468.78 Mio. EUR |
| 1406.16 Mio. EUR |
| 485.29 Mio. EUR |
| 20.88 Mio. EUR |
| -4.04 Mio. EUR |
| -0.08 EUR |
| 65.84 Mio. EUR |
| 128.47 Mio. EUR |
| 56.57 Mio. EUR |
| 2 |
| 15.01% |
| 87.97% |
| - |
| - |
| - |
| - |
| ATRICURE |
| 24.07.26 |